atovaquone
atovaquone is listed in the FDA National Drug Code directory with 6 NDC codes, marketed under brand names including MEPRON, atovaquone. Available dosage forms: suspension, powder.
Drug Details
- Generic Name
- atovaquone
- Brand Names
- MEPRON, atovaquone
- Application Number
- NDA020500
- Sponsor
- GlaxoSmithKline LLC
- NDC Codes
- 6
- Dosage Forms
- SUSPENSION, POWDER
- Routes
- ORAL
- Active Ingredients
- ATOVAQUONE
Indications and Usage
1 INDICATIONS AND USAGE Atovaquone and proguanil hydrochloride tablets are an antimalarial indicated for: • prophylaxis of Plasmodium falciparum malaria, including in areas where chloroquine resistance has been reported. ( 1.1 ) • treatment of acute, uncomplicated P. falciparum malaria. ( 1.2 ) 1.1 Prevention of Malaria Atovaquone and proguanil hydrochloride tablets are indicated for the prophylaxis of Plasmodium falciparum malaria, including in areas where chloroquine resistance has been reported. 1.2 Treatment of Malaria Atovaquone and proguanil hydrochloride tablets are indicated for the treatment of acute, uncomplicated P. falciparum malaria. Atovaquone and proguanil hydrochloride tablets have been shown to be effective in regions where the drugs chloroquine, halofantrine, mefloquine, and amodiaquine may have unacceptable failure rates, presumably due to drug resistance.